Prudential Financial Inc. Sells 147,602 Shares of Tenet Healthcare Corporation $THC

Prudential Financial Inc. reduced its holdings in Tenet Healthcare Corporation (NYSE:THC - Free Report) by 31.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 324,092 shares of the company's stock after selling 147,602 shares during the period. Prudential Financial Inc. owned approximately 0.37% of Tenet Healthcare worth $57,040,000 as of its most recent SEC filing.Top Analyst-Rated Healthcare Stocks to Watch NowA number of other institutional investors and hedge funds have also bought and sold shares of the stock. ProShare Advisors LLC raised its stake in Tenet Healthcare by 1.7% during the 2nd quarter. ProShare Advisors LLC now owns 4,118 shares of the company's stock valued at $725,000 after purchasing an additional 67 shares during the last quarter. US Bancorp DE lifted its position in shares of Tenet Healthcare by 0.8% in the 1st quarter. US Bancorp DE now owns 8,620 shares of the company's stock worth $1,159,000 after acquiring an additional 68 shares during the period. Farther Finance Advisors LLC lifted its position in Tenet Healthcare by 2.8% in the second quarter. Farther Finance Advisors LLC now owns 2,615 shares of the company's stock worth $460,000 after purchasing an additional 70 shares during the period. Signaturefd LLC lifted its stake in Tenet Healthcare by 11.2% during the second quarter. Signaturefd LLC now owns 732 shares of the company's stock worth $129,000 after purchasing an additional 74 shares during the period. Finally, Vista Investment Partners LLC boosted its stake in Tenet Healthcare by 0.3% in the 2nd quarter. Vista Investment Partners LLC now owns 25,257 shares of the company's stock valued at $4,445,000 after buying an additional 76 shares in the last quarter. Institutional investors own 95.44% of the company's stock. Get Tenet Healthcare alerts:Insider Buying and Selling at Tenet HealthcareIn other news, CEO Saumya Sutaria sold 78,762 shares of the firm's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $190.78, for a total value of $15,026,214.36. Following the transaction, the chief executive officer directly owned 368,683 shares in the company, valued at $70,337,342.74. This trade represents a 17.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Tammy Romo sold 15,099 shares of the stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $200.81, for a total value of $3,032,030.19. Following the completion of the transaction, the director directly owned 47,267 shares in the company, valued at $9,491,686.27. The trade was a 24.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 122,092 shares of company stock valued at $23,844,663. 0.81% of the stock is currently owned by company insiders. Analyst Ratings Changes3 Under-the-Radar Healthcare CompaniesSeveral equities research analysts have recently commented on the stock. Raymond James Financial set a $245.00 target price on shares of Tenet Healthcare in a research note on Wednesday, October 29th. JPMorgan Chase & Co. boosted their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an "overweight" rating in a research report on Thursday, November 13th. Mizuho raised their price objective on shares of Tenet Healthcare from $194.00 to $225.00 and gave the stock an "outperform" rating in a report on Friday, October 17th. Zacks Research downgraded Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a report on Monday, October 6th. Finally, The Goldman Sachs Group began coverage on Tenet Healthcare in a report on Tuesday, October 14th. They set a "buy" rating and a $224.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $229.69.Read Our Latest Stock Analysis on THCTenet Healthcare Price PerformanceHCA Healthcare: Temporary Setbacks, Long-Term StrengthTHC opened at $191.64 on Monday. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.63. The stock has a market capitalization of $16.84 billion, a P/E ratio of 13.14, a price-to-earnings-growth ratio of 0.89 and a beta of 1.53. The company's 50 day simple moving average is $198.72 and its 200-day simple moving average is $180.35. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $217.43. Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.33 by $0.37. The firm had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The business's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year. About Tenet Healthcare (Free Report)Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.Recommended StoriesFive stocks we like better than Tenet HealthcareThe How And Why of Investing in Oil StocksDoorDash’s Recent Stock Dip Equals 60% Upside3 Dividend Kings To ConsiderWall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026ESG Stocks, What Investors Should KnowMeta Wins FTC Fight, Keeps Instagram Growth Machine IntactWant to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Tenet Healthcare Right Now?Before you consider Tenet Healthcare, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here